Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125873191 | 12587319 | 1 | I | 20160713 | 20160725 | 20160725 | EXP | PHHY2016US097231 | SANDOZ | 60.00 | YR | F | Y | 0.00000 | 20160725 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125873191 | 12587319 | 1 | PS | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 40 MG, UNK | Y | U | 77575 | 40 | MG | ||||||
125873191 | 12587319 | 2 | I | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | Y | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125873191 | 12587319 | 1 | Hyperlipidaemia |
125873191 | 12587319 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125873191 | 12587319 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125873191 | 12587319 | Drug interaction | |
125873191 | 12587319 | Rhabdomyolysis | |
125873191 | 12587319 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |